Dysregulation of the CD38/NAD axis has been implicated in the pathogenesis of numerous rheumatic diseases including systemic sclerosis, SLE and rheumatoid arthritis.4 5 Hyperactivation of CD38 promotes chronic inflammation, likely through a B-cell-dependent mechanism.6 This evidence concerns the gene CD38 and rheumatic disorder.